CUSIP: 03476J107
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,529,626
-
Share change
-
-489,764
-
Total reported value
-
$13,840,000
-
Price per share
-
$2.12
-
Number of holders
-
46
-
Value change
-
-$1,437,946
-
Number of buys
-
11
-
Number of sells
-
30
Quarterly Holders Quick Answers
What is CUSIP 03476J107?
CUSIP 03476J107 identifies ANGN - ANGION BIOMEDICA CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2022
-
Previous quarter:
Q4 2021
Recent filing periods for CUSIP 03476J107:
Institutional Holders of ANGION BIOMEDICA CORP - COM (ANGN) as of Q1 2022
As of 31 Mar 2022,
ANGION BIOMEDICA CORP - COM (ANGN) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,529,626 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, CM Management, LLC, LAKE STREET ADVISORS GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.